Dr. Marco A. Barzallo, MD

Dr. Barzallo practices at Graham Hospital in Canton, Illinois, part of Graham Health System.

Dr. Barzallo's NPI, 1316971823, was assigned on July 10, 2006. Dr. Barzallo graduated from Universidad Catolica de Santiago de Guayaquil in 1993. Dr. Barzallo holds Illinois license 036114162.

Dr. Barzallo's primary practice is Graham Hospital, at 210 West Walnut Street, Canton, IL 61520 in Fulton County. The practice phone is (309) 647-5240.

Dr. Barzallo's primary practice is Graham Hospital in Canton, Illinois, part of Graham Health System. Dr. Barzallo is also affiliated with OSF Saint Francis Medical Center. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Barzallo to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barzallo practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Barzallo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Barzallo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Barzallo's licenses on file in 2 states: Illinois and Iowa.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Barzallo treats.

CMS data shows 3,085 Medicare services from Dr. Barzallo across 32 procedure codes in 2024, for 1,442 Medicare patients. Medicare paid $202,553 for them.

CMS counts 1,442 Medicare patients who saw Dr. Barzallo in 2024. The largest group is 75 to 84, with 612 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barzallo's median patient age at 77, with 45% women.

In 2024, Dr. Barzallo wrote 6,960 Medicare Part D claims for 857 patients. 87% of them were for generic drugs. CMS names the drug for 6,766 of them, across 47 drugs with 11 or more claims each, at $1,027,159 in total drug cost. In 2023, CMS named 6,371 claims across 46 drugs.

Dr. Barzallo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barzallo as offering telehealth. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Barzallo, more than 58% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Barzallo, published from 2019 to 2023. 2019 was the busiest year, with 3. The most frequent topics are Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement. Dr. Barzallo has published most often in Cureus. Dr. Barzallo's most frequent co-authors are Sudhir Mungee, MD, Mansoor Ahmad, MD and Jay Nitin Patel, MD.

CMS Open Payments shows 284 general payments to Dr. Barzallo from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Edwards Lifesciences Corporation paid the most, $6,488.

Dmand AI lists 2 awards for Dr. Barzallo, most recently CMS Stage 1 EHR in 2013.

Dr. Barzallo graduated from Universidad Catolica de Santiago de Guayaquil in 1993. Dr. Barzallo is a member of ACC.

Dr. Barzallo is in network with 19 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.